DocGo Inc. Operating Income
DocGo Inc. (DCGO) reported Operating Income of -$17.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-17
- DocGo Inc. operating income (loss) for the quarter ending 2026-06-30 was -$17.92M.
- DocGo Inc. operating income (loss) for the quarter ending 2026-03-31 was -$18.71M.
- DocGo Inc. operating income (loss) for the quarter ending 2025-12-31 was -$104.58M.
- DocGo Inc. operating income (loss) for the quarter ending 2025-09-30 was -$41.98M, a 514.07% decline year-over-year.
- DocGo Inc. operating income (loss) for fiscal 2025 was -$178.03M, a 720.57% decline from fiscal 2024.
- DocGo Inc. operating income (loss) for fiscal 2024 was $28.69M, a 90.56% increase from fiscal 2023.
- DocGo Inc. operating income (loss) for fiscal 2023 was $15.05M, a 31.04% decline from fiscal 2022.
- DocGo Inc. operating income (loss) for fiscal 2022 was $21.83M, a 42.16% increase from fiscal 2021.
| Period end | Operating Income (Loss) 2 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 5 month | Operating Income (Loss) 5 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$17.92M 10-Q · filed 2026-08-17 | -$36.63M 10-Q · filed 2026-08-17 | -$141.21M derived: sum of 3 quarters · filed 2026-08-17 | -$183.19M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2026-03-31 | -$18.71M 10-Q · filed 2026-05-11 | -$123.29M derived: sum of 2 quarters · filed 2026-05-11 | -$165.27M derived: sum of 3 quarters · filed 2026-05-11 | -$182.75M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2025-12-31 | -$104.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$146.56M derived: sum of 2 quarters · filed 2026-03-16 | -$164.04M derived: sum of 3 quarters · filed 2026-08-17 | -$178.03M 10-K · filed 2026-03-16 | ||||||
| 2025-09-30 | -$41.98M 10-Q · filed 2025-11-10 | -$59.46M derived: sum of 2 quarters · filed 2026-08-17 | -$73.45M 10-Q · filed 2025-11-10 | -$80.93M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2025-06-30 | -$17.48M 10-Q · filed 2026-08-17 | -$31.48M 10-Q · filed 2026-08-17 | -$38.95M derived: sum of 3 quarters · filed 2026-08-17 | -$28.81M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2025-03-31 | -$14.00M 10-Q · filed 2026-05-11 | -$21.47M derived: sum of 2 quarters · filed 2026-05-11 | -$11.33M derived: sum of 3 quarters · filed 2026-05-11 | -$1.18M derived: sum of 4 quarters · filed 2026-05-11 | ||||||
| 2024-12-31 | -$7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.66M derived: sum of 2 quarters · filed 2026-03-16 | $12.81M derived: sum of 3 quarters · filed 2026-03-16 | $28.69M 10-K · filed 2026-03-16 | ||||||
| 2024-09-30 | $10.14M 10-Q · filed 2025-11-10 | $20.29M derived: sum of 2 quarters · filed 2025-11-10 | $36.16M 10-Q · filed 2025-11-10 | $47.84M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2024-06-30 | $10.15M 10-Q · filed 2025-08-07 | $26.02M 10-Q · filed 2025-08-07 | $37.70M derived: sum of 3 quarters · filed 2026-03-16 | $46.41M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2024-03-31 | $15.88M 10-Q · filed 2025-05-08 | $27.55M derived: sum of 2 quarters · filed 2026-03-16 | $36.26M derived: sum of 3 quarters · filed 2026-03-16 | $37.83M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2023-12-31 | $11.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $20.38M derived: sum of 2 quarters · filed 2026-03-16 | $21.96M derived: sum of 3 quarters · filed 2026-03-16 | $15.05M 10-K · filed 2026-03-16 | ||||||
| 2023-09-30 | $8.71M 10-Q · filed 2024-11-07 | $10.28M derived: sum of 2 quarters · filed 2024-11-07 | $3.38M 10-Q · filed 2024-11-07 | $3.46M derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2023-06-30 | $1.58M 10-Q · filed 2024-08-07 | -$5.33M 10-Q · filed 2024-08-07 | -$5.25M derived: sum of 3 quarters · filed 2025-02-27 | -$1.05M derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2023-03-31 | -$6.90M 10-Q · filed 2024-05-08 | -$6.82M derived: sum of 2 quarters · filed 2025-02-27 | -$2.62M derived: sum of 3 quarters · filed 2025-02-27 | $4.83M derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2022-12-31 | $80.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.28M derived: sum of 2 quarters · filed 2025-02-27 | $11.74M derived: sum of 3 quarters · filed 2025-02-27 | $21.83M 10-K · filed 2025-02-27 | ||||||
| 2022-09-30 | $4.20M 10-Q · filed 2023-11-06 | $11.66M derived: sum of 2 quarters · filed 2023-11-06 | $21.75M 10-Q · filed 2023-11-06 | $37.20M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-06-30 | $7.46M 10-Q · filed 2023-08-08 | $17.55M 10-Q · filed 2023-08-08 | $33.01M derived: sum of 3 quarters · filed 2024-02-28 | $34.52M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-03-31 | $10.09M 10-Q · filed 2023-05-09 | $25.55M derived: sum of 2 quarters · filed 2024-02-28 | $27.07M derived: sum of 3 quarters · filed 2024-02-28 | $27.33M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2021-12-31 | $15.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $16.97M derived: sum of 2 quarters · filed 2024-02-28 | $17.23M derived: sum of 3 quarters · filed 2024-02-28 | $15.36M 10-K · filed 2024-02-28 | ||||||
| 2021-09-30 | $1.52M 10-Q · filed 2022-11-08 | -$348.32K 10-Q · filed 2021-11-15 | $1.78M derived: sum of 2 quarters · filed 2022-11-08 | -$95.98K 10-Q · filed 2022-11-08 | -$976.49K 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $258.76K 10-Q · filed 2022-08-09 | -$245.34K 10-Q · filed 2021-08-11 | -$1.62M 10-Q · filed 2022-08-09 | -$628.16K 10-Q · filed 2021-08-11 | ||||||
| 2021-03-31 | -$1.87M 10-Q · filed 2022-05-10 | -$382.82K 10-Q · filed 2021-06-03 | ||||||||
| 2020-12-31 | -$168.83K 10-K/A · filed 2021-11-24 | -$168.83K 10-K · filed 2021-03-30 | -$14.76M 10-K · filed 2022-03-15 | |||||||
| 2020-09-30 | -$2.06K 10-Q/A · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |